FA
TMO icon

Forefront Analytics’s Thermo Fisher Scientific TMO Stock Holding History

Forefront Analytics’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
669
+90
+16% +$43.2K 0.36% 25
2026
Q1 		$285K Sell
579
-7
-1% -$3.8K 0.26% 27
2025
Q4 		$339K Buy
+586
New +$331K 0.3% 28
2025
Q3 		– Sell
-891
Closed -$361K – 45
2025
Q2 		$361K Buy
891
+367
+70% +$153K 0.4% 26
2025
Q1 		$262K Buy
524
+111
+27% +$60.1K 0.3% 28
2024
Q4 		$215K Sell
413
-17
-4% -$9.35K 0.1% 53
2024
Q3 		$267K Sell
430
-26
-6% -$15.4K 0.13% 54
2024
Q2 		$253K Sell
456
-50
-10% -$28.6K 0.12% 56
2024
Q1 		$295K Buy
506
+69
+16% +$38.7K 0.14% 54
2023
Q4 		$233K Buy
+437
New +$212K 0.11% 54
2023
Q3 		– Sell
-427
Closed -$223K – 71
2023
Q2 		$223K Sell
427
-48
-10% -$25.9K 0.13% 52
2023
Q1 		$274K Buy
+475
New +$268K 0.14% 56
2022
Q2 		– Sell
-528
Closed -$317K – 73
2022
Q1 		$317K Buy
528
+20
+4% +$11.5K 0.12% 44
2021
Q4 		$338K Buy
508
+14
+3% +$8.74K 0.11% 42
2021
Q3 		$283K Sell
494
-20
-4% -$11K 0.1% 46
2021
Q2 		$260K Buy
+514
New +$243K 0.1% 49

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Forefront Analytics's TMO Position: Q2 2026 in Review

Forefront Analytics increased its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, buying an estimated $43.2K and bringing the position to 669 shares worth $336K. The position accounts for 0.36% of the portfolio, ranked #25.

Forefront Analytics first reported a position in TMO in Q2 2021 and has held it in 16 quarters since. The position peaked at $361K in Q2 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Forefront Analytics held 669 shares of Thermo Fisher Scientific worth $336K as of Q2 2026.
  • Forefront Analytics bought 90 Thermo Fisher Scientific shares in Q2 2026, an estimated $43.2K.
  • Thermo Fisher Scientific made up 0.36% of Forefront Analytics's portfolio in Q2 2026, its #25 holding.
  • Forefront Analytics first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 16 quarters since.
  • Forefront Analytics's Thermo Fisher Scientific position peaked at $361K in Q2 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Forefront Analytics's 13F filing for Q2 2026, filed 13 Aug 2026.